HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P G Steg Selected Research

P G Steg Research Topics

Disease

11Myocardial Infarction
11/2020 - 06/2000
7Hemorrhage
11/2020 - 08/2006
6Acute Coronary Syndrome
11/2020 - 11/2001
4Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 03/2001
4Coronary Artery Disease (Coronary Atherosclerosis)
10/2020 - 11/2000
4Thrombosis (Thrombus)
09/2015 - 03/2007
4ST Elevation Myocardial Infarction
09/2013 - 08/2006
4Infarction (Infarctions)
03/2007 - 02/2001
3Heart Failure
10/2015 - 03/2001
2Peripheral Arterial Disease
10/2020 - 06/2010
2Stroke (Strokes)
10/2020 - 08/2009
2Diabetes Mellitus
10/2015 - 07/2013
2Left Ventricular Dysfunction
02/2011 - 01/2008
2Pathologic Constriction (Stenosis)
03/2007 - 06/2000
2Hyperplasia
06/2001 - 02/2000
1Anemia
11/2020
1Non-ST Elevated Myocardial Infarction
11/2020
1Vascular Diseases (Vascular Disease)
01/2019
1Type 2 Diabetes Mellitus (MODY)
07/2013
1Albuminuria
07/2013
1Diabetic Retinopathy (Retinopathy, Diabetic)
07/2013
1Inflammation (Inflammations)
07/2013
1Insulin Resistance
07/2013
1Ventricular Remodeling
02/2011
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
06/2010
1Heart Arrest (Cardiac Arrest)
02/2007
1Hypertension (High Blood Pressure)
08/2006
1Cardiomyopathies (Cardiomyopathy)
09/2004
1Pheochromocytoma
09/2004
1Angina Pectoris
03/2001
1Myocarditis (Carditis)
03/2001
1Atherosclerotic Plaque (Atheroma)
02/2000
1Stable Angina
02/2000

Drug/Important Bio-Agent (IBA)

4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2020 - 11/2000
3omega-Chloroacetophenone (Mace)IBA
01/2021 - 10/2011
3AnticoagulantsIBA
10/2020 - 08/2006
3IvabradineIBA
09/2013 - 01/2008
2Heparin (Liquaemin)FDA LinkGeneric
11/2020 - 08/2006
2saxagliptinFDA Link
10/2015 - 07/2013
2Glycoproteins (Glycoprotein)IBA
02/2008 - 08/2006
2Fibrinolytic Agents (Antithrombotic Agents)IBA
12/2007 - 04/2001
2CreatinineIBA
02/2007 - 08/2006
2Abciximab (ReoPro)FDA Link
02/2003 - 11/2001
1Hemoglobins (Hemoglobin)IBA
11/2020
1Troleandomycin (TAO)FDA Link
11/2020
1otamixabanIBA
11/2020
1Eptifibatide (Integrilin)FDA Link
11/2020
1RivaroxabanIBA
10/2020
1Antiphospholipid AntibodiesIBA
09/2015
1Insulin (Novolin)FDA Link
07/2013
1Biomarkers (Surrogate Marker)IBA
07/2013
1Dipeptidyl-Peptidase IV InhibitorsIBA
07/2013
1Clopidogrel (Plavix)FDA Link
10/2011
1Aryldialkylphosphatase (Paraoxonase)IBA
10/2011
1Cytochrome P-450 CYP2C19IBA
10/2011
1Pharmaceutical PreparationsIBA
01/2011
1Antihypertensive Agents (Antihypertensives)IBA
06/2010
1N 30IBA
08/2009
1Platelet Membrane Glycoprotein IIbIBA
02/2008
1FibrinIBA
12/2007
1Coenzyme A (CoA)IBA
08/2006
1Biological ProductsIBA
09/2004
1Adrenergic Agents (Adrenergic Drugs)IBA
09/2004
1LipidsIBA
07/2002
1Platelet Glycoprotein GPIIb-IIIa ComplexIBA
11/2001
1Thallium-201IBA
03/2001
1Indium-111IBA
03/2001
1Trimetazidine (Vastarel)IBA
02/2001
1MyoglobinIBA
02/2001
1Interleukin-10 (Interleukin 10)IBA
02/2000
1PhosphatidylserinesIBA
02/2000
1CytokinesIBA
02/2000

Therapy/Procedure

5Percutaneous Coronary Intervention
09/2013 - 08/2005
5Stents
03/2007 - 02/2000
4Therapeutics
10/2020 - 02/2001
2Secondary Prevention
01/2019 - 07/2002
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
02/2007 - 03/2001
1Blood Transfusion (Blood Transfusions)
11/2020
1Duration of Therapy
09/2015
1Surgical Amputation (Amputations)
07/2013
1Treatment Delay
12/2007
1Thrombolytic Therapy
12/2007
1Drug-Eluting Stents
03/2007
1Myocardial Revascularization
03/2002